June 26 (Reuters) – Unilever is exploring a bid for Thorne, a U.S. supplements maker valued at up to $4 billion, the Financial Times reported on Friday. Reuters could not immediately verify the report
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Why the Future of Work Still Needs a Room: Lessons from XLRI’s Metamorphose 2026
New Delhi [India], October 2: Senior HR leaders from more than 80 organisations gathered at…
Tsitsipas, Tiafoe bow out as Vacherot, Fils progress at Japan Open
VIDEO SHOWS: HIGHLIGHTS FROM ROUND TWO ACTION AT JAPAN OPEN - AN ATP 500 TOURNAMENT…
UPDATE 1-Hedge funds account for around 50% of French spread blowout, Fidelity says
(Adds additional quotes, details) LONDON, Oct 2 (Reuters) - Hedge funds have played a big…
